Shawn Seamans, Chief Commercial Officer, CoverMyMeds | Authors | Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking ...

CMS has demonstrated willingness to constrain coverage and now sets market economics via IRA negotiation/MFP, making Medicare assumptions central to launch price, sequencing, and life-cycle strategy.

In the final installment of his interview with Pharmaceutical Commerce, Cencora's Ameer Ali outlines how supply chain stakeholders should prepare systems, processes and trading partners for the shift ...

In the final installment of his interview with Pharmaceutical Commerce, Cencora's Gregg Gorniak looks back at DSCSA's ...

As pharmaceutical companies move AI into patient access and support operations, most still rely on manual sampling and ...

In this week's Pharma Pulse, DHL breaks ground on a new cold chain hub at Singapore's Changi Airport, a new report finds ...

Legislative paths for GENEROUS, GLOBE, and GUARD remain blocked by intra-party resistance and intensifying midterm dynamics, ...

Direct-to-consumer drug marketing signals high-value, high-velocity targets, driving theft and diversion of GLP-1s and other ...

Newly added signatories include Alcon, Astellas, BeOne, BridgeBio, CSL, Kyowa Kirin, Sun, Teva, and UCB, spanning hemophilia, ...

Cencora's Gregg Gorniak breaks down what separates basic DSCSA compliance from using it to streamline transactions and strengthen trading partnerships. Meeting DSCSA's letter and building genuine ...

The biosimilar market is smaller but rapidly expanding. As more blockbuster biologics lose exclusivity across immunology, ...